Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease
Originally published by Justin Jackson , Medical Xpress, on July 6, 2023 Thinking about the time. Credit: Freeimages.com Researchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzheimer's disease (AD) . In a paper, "Proteomics of brain, CSF, and blood identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease ," published in Science Translational Medicine , the researchers identify specific and shared proteomic changes associated with sporadic Alzheimer's disease (AD) across brain tissue, cerebrospinal fluid (CSF), and blood .